• 1
    ) Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res., 50, 61306138 (1990).
  • 2
    ) Morikawa, K., Walker, S. M., Jessup, J. M. and Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48, 19431948 (1988).
  • 3
    ) Li, X. B., Hamada, J., Takeichi, N., Hosokawa, M. and Kobayashi, H. Timing of UFT administration combined with surgical operation in pulmonary metastasis of rat mammary carcinoma. Jpn. J. Cancer Chemother., 16, 23812385 (1989).
  • 4
    ) Giavazzi, R., Campbell, D. E., Jessup, J. M., Cleary, K. and Fidler, I. J. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res., 46, 19281933 (1986).
  • 5
    ) Fidler, I. J. and Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893895 (1977).
  • 6
    ) Raz, A., Bucana, C., McLellan, W. and Fidler, I. J. Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential. Nature, 284, 363364 (1980).
  • 7
    ) Masui, T., Nakanishi, H., Inada, K., Imai, T., Mizoguchi, Y., Yada, H., Futakuchi, M., Shirai, T. and Tatematsu, M. Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes. Cancer Lett., 112, 3345 (1997).
  • 8
    ) Watanabe, T., Katsura, Y., Yoshitake, A., Masataki, H. and Mori, T. IPAP: image processor for analytical pathology. J. Toxicol. Pathol., 7, 353361 (1994).
  • 9
    ) Enzmann, H., Zerban, H., Kopp, S. A., Loser, E. and Bannach, P. Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis. Carcinogenesis, 16, 15131518 (1995).
  • 10
    ) Lijinsky, W., Kovatch, R. M., Riggs, C. W. and Walters, P. T. Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats. Cancer Res., 48, 20892095 (1988).
  • 11
    ) Lijinsky, W. Metastasizing tumors in rats treated with alkylating carcinogens. Carcinogenesis, 16, 675681 (1995).
  • 12
    ) Volm, M., Zerban, H., Mattern, J. and Efferth, T. Overexpression of P-glycoprotein in rat hepatocellular carcinomas induced with N-nitrosomorpholine. Carcinogenesis, 11, 169172 (1990).
  • 13
    ) Weber, E. and Bannasch, P. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Carcinogenesis, 15, 12351242 (1994).
  • 14
    ) Takeichi, M. Cadherin cell adhesion receptors as a mor-phogenetic regulator. Science, 251, 14511455 (1991).
  • 15
    ) Takeichi, M., Watabe, M., Shibamoto, S. and Ito, F. Cadherin-dependent organization and disorganization of epithelial architecture. Princess Takamatsu Symp., 24, 2837 (1994).
  • 16
    ) Takeichi, M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol., 7, 619627 (1995).
  • 17
    ) Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F., Schaafsma, H. E., Debruyne, F. M. and Isaacs, W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52, 51045109 (1992).
  • 18
    ) Navarro, P., Gomez, M., Pizarro, A., Gamallo, C., Quintanilla, M. and Cano, A. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J. Cell Biol., 115, 517533 (1991).
  • 19
    ) Wakatsuki, S., Watanabe, R., Saito, K., Saito, T., Katagiri, A., Sato, S. and Tomita, Y. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder. Cancer Lett., 103, 1117 (1996).
  • 20
    ) Mbalaviele, G., Dunstan, C. R., Sasaki, A., Williams, P. J., Mundy, G. R. and Yoneda, T. E-Cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res., 56, 40634070 (1996).
  • 21
    ) Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W. and van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107119 (1991).
  • 22
    ) Sundfeldt, K., Piontkewitz, Y., Ivarsson, K., Nilsson, O., Hellberg, P., Brannstrom, M., Janson, P. O., Enerback, S. and Hedin, L. E-Cadherin expression in human epithelial ovarian cancer and normal ovary. Int. J. Cancer, 74, 275280 (1997).
  • 23
    ) Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H. and Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 392, 190193 (1998).